Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: CALGB N0879 Principal Investigator: Linette, Gerald
Title: A Randomized Phase II Trial of Carboplatin, Paclitaxel, Bevacizumab, with or without Everolimus for Therapy of Metastatic Malignant Melanoma (N0879)
Phase: II Disease Site: Melanoma, Skin
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu
Description:
There are two purposes of this research study. They are:
Find out what effects (good and bad) the combination of study drugs has on patients and their melanoma
Find out what effects the combination of study drugs has on each patient's immune system and the way their tumor grows
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)